Pāriet uz galveno navigāciju Pāriet uz meklēšanu Pāriet uz galveno saturu

Nanoparticles for intravascular applications: Pcharacterization and cytotoxicity testing

  • Jasmin Matuszak
  • , Jens Baumgartner
  • , Jan Zaloga
  • , Maya Juenet
  • , Acarília Eduardo Da Silva
  • , Danielle Franke
  • , Gunter Almer
  • , Isabelle Texier
  • , Damien Faivre
  • , Josbert M. Metselaar
  • , Fabrice P. Navarro
  • , Cédric Chauvierre
  • , Ruth Prassl
  • , László Dézsi
  • , Rudolf Urbanics
  • , Christoph Alexiou
  • , Harald Mangge
  • , János Szebeni
  • , Didier Letourneur
  • , Iwona Cicha*
  • *Šī darba korespondējošais autors
  • Friedrich-Alexander University Erlangen-Nürnberg
  • Max Planck Institute of Colloids and Interfaces
  • Université Paris Cité
  • University of Twente
  • nanoPET Pharma GmbH
  • Medical University of Graz
  • Université Grenoble Alpes
  • RWTH Aachen University
  • Semmelweis University
  • SeroScience

Zinātniskās darbības rezultāts: Devums žurnālamZinātniskais raksts (žurnālā)koleģiāli recenzēts

54 Atsauces (Scopus)

Kopsavilkums

Aim: We report the physicochemical analysis of nanosystems intended for cardiovascular applications and their toxicological characterization in static and dynamic cell culture conditions. Methods: Size, polydispersity and ζ-potential were determined in 10 nanoparticle systems including liposomes, lipid nanoparticles, polymeric and iron oxide nanoparticles. Nanoparticle effects on primary human endothelial cell viability were monitored using real-time cell analysis and live-cell microscopy in static conditions, and in a flow model of arterial bifurcations. Results & conclusions: The majority of tested nanosystems were well tolerated by endothelial cells up to the concentration of 100 μg/ml in static, and up to 400 μg/ml in dynamic conditions. Pilot experiments in a pig model showed that intravenous administration of liposomal nanoparticles did not evoke the hypersensitivity reaction. These findings are of importance for future clinical use of nanosystems intended for intravascular applications.

OriģinālvalodaAngļu
Lapas (no-līdz)597-616
Lapu skaits20
ŽurnālsNanomedicine
Sējums11
Izdevuma numurs6
DOIs
Publikācijas statussPublicēts - marts 2016
Ārēji publicēts

Nospiedums

Uzziniet vairāk par pētniecības tēmām “Nanoparticles for intravascular applications: Pcharacterization and cytotoxicity testing”. Kopā tie veido unikālu nospiedumu.

Citēt šo